The Prevention of Cytomegalovirus Disease in Renal Transplantation
- 1 September 1990
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 16 (3) , 175-188
- https://doi.org/10.1016/s0272-6386(12)81016-x
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Elevated antibody titers against cytomegalovirus among patients with testicular cancerInternational Journal of Cancer, 1988
- In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovirDiagnostic Microbiology and Infectious Disease, 1987
- Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant RecipientsNew England Journal of Medicine, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Interferon for Prevention of Cytomegalovirus Reactivation in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal TransplantationNew England Journal of Medicine, 1983
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979